'Nanopack' cell therapy targets inflammation in multiple sclerosis

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous system and scrambles communication between the brain and body. MS, for which there is no single cause or cure, affects people of all demographics with symptoms like fatigue, memory difficulties, vision impairment and mobility loss.